Dramatic reduction in primary endpoint with precision testing in stable patients with suspected CAD - PACE-CME

Dramatic reduction in primary endpoint with precision testing in stable patients with suspected CAD

Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Recommended

Long-term efficacy and safety of intravenous iron in HF
Long-term efficacy and safety of intravenous iron in HF
AHA 2022
Long-term efficacy and safety of intravenous iron in HF
Mindfulness-based BP-reduction program outperforms enhanced usual care
Mindfulness-based BP-reduction program outperforms enhanced usual care
AHA 2022
Mindfulness-based BP-reduction program outperforms enhanced usual care
- Eric Loucks, PhD
Composite endpoint of CV death or kidney disease worsening reduced by SGLT2i in CKD
Composite endpoint of CV death or kidney disease worsening reduced by SGLT2i in CKD
AHA 2022
Composite endpoint of CV death or kidney disease worsening reduced by SGLT2i in CKD
- David Preiss, PhD
Is one diuretic better than the other diuretic in veterans with hypertension?
Is one diuretic better than the other diuretic in veterans with hypertension?
AHA 2022
Is one diuretic better than the other diuretic in veterans with hypertension?
- Areef Ishani, MD